Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …

Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer, and
small-molecule radiopharmaceuticals targeting PSMA rapidly detect the location and extent …

The prostate-specific membrane antigen (PSMA) is expressed in epithelial cells of the
prostate and highly overexpressed in 95% of advanced prostate cancers. The aims of this …

Purpose: Prostate-specific membrane antigen (PSMA) is a cell surface protein that is
overexpressed in prostate cancer, including hormone-refractory and metastatic disease. Our …

Introduction Prostate-specific membrane antigen (PSMA) is a well-established target in the
development of radiopharmaceuticals for the diagnosis and therapy of prostate cancer …

The prostate-specific membrane antigen (PSMA) is increasingly recognized as a viable
target for imaging and therapy of cancer. We prepared seven 99mTc/Re-labeled compounds …

Background Prostate-specific membrane antigen (PSMA) is highly over-expressed in
advanced prostate cancers. 68 Ga-labeled PSMA inhibitors (iPSMA) are currently used for …

Technetium-99m, the most commonly used radionuclide in nuclear medicine, can be
attached to biologically important molecules through a variety of chelating agents, the choice …

Despite significant research activities and subsequent progress made in the fight against
cancer over the last few decades, prostate cancer remains a major health-related problem …

In recent years, several radioligands targeting prostate-specific membrane antigen (PSMA)
have been clinically introduced as a new class of theranostic radiopharmaceuticals for the …